---
title: "Adial Pharmaceuticals announces annual shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295517725.md"
description: "Adial Pharmaceuticals announced its 2026 annual shareholder meeting in Charlottesville, Virginia. Key voting items include issuing shares from Series A preferred stock conversions related to the Azora acquisition, assuming Azora options, and exercising various warrants. Shareholders will also vote on increasing authorized common shares to 500 million and adopting new equity plans."
datetime: "2026-08-11T10:08:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295517725.md)
  - [en](https://longbridge.com/en/news/295517725.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295517725.md)
generator: "portal-rs"
---

# Adial Pharmaceuticals announces annual shareholder meeting

-   Adial Pharmaceuticals will hold its 2026 annual stockholder meeting in September 2026 in Charlottesville, Virginia. \* Votes are scheduled on issuing 12,930,617 common shares from conversion of Series A Non-Voting Convertible Preferred Stock tied to the Azora acquisition. \* Other items include approval to issue up to 1,177,782 shares from assumed Azora options, up to 11,780,948 shares from Initial Closing Pre-Funded Warrants. \* Stockholders will also vote on issuing up to 23,561,896 shares from Milestone Pre-Funded Warrants and Milestone Incentive Warrants, plus raising authorized common shares to 500,000,000. \* Additional proposals cover issuing up to 552,940 shares from Series F warrants, amending the 2017 equity plan, adopting 2026 equity plan and 2026 employee stock purchase plan. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-087445), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)

## Related News & Research

- [Adial Pharmaceuticals reports $52.0M Q2 net loss, cash $28.7M after $32M financing](https://longbridge.com/en/news/296097766.md)
- [MiniMed Group announces annual shareholder meeting](https://longbridge.com/en/news/296649574.md)
- [Aptevo Therapeutics announces special shareholder meeting](https://longbridge.com/en/news/296649507.md)
- [Profusa announces special shareholder meeting](https://longbridge.com/en/news/296272150.md)
- [Western Forest Products announces annual shareholder meeting](https://longbridge.com/en/news/296542329.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**